84 related articles for article (PubMed ID: 25940181)
21. ATAD2 overexpression is associated with progression and prognosis in colorectal cancer.
Hou M; Huang R; Song Y; Feng D; Jiang Y; Liu M
Jpn J Clin Oncol; 2016 Mar; 46(3):222-7. PubMed ID: 26819280
[TBL] [Abstract][Full Text] [Related]
22. Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers.
Alqurashi N; Gopalan V; Smith RA; Lam AK
Hum Pathol; 2013 Oct; 44(10):2089-96. PubMed ID: 23773481
[TBL] [Abstract][Full Text] [Related]
23. Long non‑coding nuclear paraspeckle assembly transcript 1 acts as prognosis biomarker and increases cell growth and invasion in cervical cancer by sequestering microRNA‑101.
Wang L; Zhu H
Mol Med Rep; 2018 Feb; 17(2):2771-2777. PubMed ID: 29207151
[TBL] [Abstract][Full Text] [Related]
24. Deleted in malignant brain tumor 1 is a novel prognostic marker in colorectal cancer.
Park HS; Kim BC; Yeo HY; Kim KH; Yoo BC; Park JW; Chang HJ
Oncol Rep; 2018 May; 39(5):2279-2287. PubMed ID: 29498404
[TBL] [Abstract][Full Text] [Related]
25. [Association of peripheral nerve invasion with clinicopathological factors and prognosis of colorectal cancer].
Han D; Wei Y; Wang X; Wang G; Chen Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):62-66. PubMed ID: 28105622
[TBL] [Abstract][Full Text] [Related]
26. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY
Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319
[TBL] [Abstract][Full Text] [Related]
27. Expression of ITGB1 predicts prognosis in colorectal cancer: a large prospective study based on tissue microarray.
Liu QZ; Gao XH; Chang WJ; Gong HF; Fu CG; Zhang W; Cao GW
Int J Clin Exp Pathol; 2015; 8(10):12802-10. PubMed ID: 26722470
[TBL] [Abstract][Full Text] [Related]
28. Decreased expression of dual specificity phosphatase 22 in colorectal cancer and its potential prognostic relevance for stage IV CRC patients.
Yu D; Li Z; Gan M; Zhang H; Yin X; Tang S; Wan L; Tian Y; Zhang S; Zhu Y; Lai M; Zhang D
Tumour Biol; 2015 Nov; 36(11):8531-5. PubMed ID: 26032091
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of microRNA-183 in human colorectal cancer and its clinical significance.
Zhou T; Zhang GJ; Zhou H; Xiao HX; Li Y
Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):229-33. PubMed ID: 24150523
[TBL] [Abstract][Full Text] [Related]
30. Up-regulation of mir-10b predicate advanced clinicopathological features and liver metastasis in colorectal cancer.
Jiang H; Liu J; Chen Y; Ma C; Li B; Hao T
Cancer Med; 2016 Oct; 5(10):2932-2941. PubMed ID: 27592860
[TBL] [Abstract][Full Text] [Related]
31. DLL4 as a predictor of pelvic lymph node metastasis and a novel prognostic biomarker in patients with early-stage cervical cancer.
Yang S; Liu Y; Xia B; Deng J; Liu T; Li Q; Yang Y; Wang Y; Ning X; Zhang Y; Xiao M
Tumour Biol; 2016 Apr; 37(4):5063-74. PubMed ID: 26546434
[TBL] [Abstract][Full Text] [Related]
32. ROR1 expression as a biomarker for predicting prognosis in patients with colorectal cancer.
Zhou JK; Zheng YZ; Liu XS; Gou Q; Ma R; Guo CL; Croce CM; Liu L; Peng Y
Oncotarget; 2017 May; 8(20):32864-32872. PubMed ID: 28427197
[TBL] [Abstract][Full Text] [Related]
33. Nuclear orphan receptor NR4A2 confers chemoresistance and predicts unfavorable prognosis of colorectal carcinoma patients who received postoperative chemotherapy.
Han Y; Cai H; Ma L; Ding Y; Tan X; Liu Y; Su T; Yu Y; Chang W; Zhang H; Fu C; Cao G
Eur J Cancer; 2013 Nov; 49(16):3420-30. PubMed ID: 23809767
[TBL] [Abstract][Full Text] [Related]
34. Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance.
Gopalan V; Pillai S; Ebrahimi F; Salajegheh A; Lam TC; Le TK; Langsford N; Ho YH; Smith RA; Lam AK
Mol Carcinog; 2014 Feb; 53 Suppl 1():E36-44. PubMed ID: 24009195
[TBL] [Abstract][Full Text] [Related]
35. Nup88 expression in normal mucosa, adenoma, primary adenocarcinoma and lymph node metastasis in the colorectum.
Zhang ZY; Zhao ZR; Jiang L; Li JC; Gao YM; Cui DS; Wang CJ; Schneider J; Wang MW; Sun XF
Tumour Biol; 2007; 28(2):93-9. PubMed ID: 17264541
[TBL] [Abstract][Full Text] [Related]
36. Prognostic impact of lymph node skip metastasis in Stage III colorectal cancer.
Bao F; Zhao LY; Balde AI; Liu H; Yan J; Li TT; Chen H; Li GX
Colorectal Dis; 2016 Sep; 18(9):O322-9. PubMed ID: 27438774
[TBL] [Abstract][Full Text] [Related]
37. miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer.
Ma Y; Zhang P; Wang F; Zhang H; Yang J; Peng J; Liu W; Qin H
Gut; 2012 Oct; 61(10):1447-53. PubMed ID: 22052060
[TBL] [Abstract][Full Text] [Related]
38. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of lymph node metastasis in patients with T1-stage colorectal cancer from multiple centers in China.
Sun ZQ; Ma S; Zhou QB; Yang SX; Chang Y; Zeng XY; Ren WG; Han FH; Xie X; Zeng FY; Sun XT; Wang GX; Li Z; Zhang ZY; Song JM; Liu JB; Yuan WT
World J Gastroenterol; 2017 Dec; 23(48):8582-8590. PubMed ID: 29358866
[TBL] [Abstract][Full Text] [Related]
40. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
Stanisavljević L; Myklebust MP; Leh S; Dahl O
Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]